ESTHMR إستثمر

October Pharma Co. OCPH

اكتوبر فارما ش م م

Health Care & PharmaceuticalsEgyptian Exchange

227.00 EGP

+6.10%

Close of Thu 1 Oct 2026

Market value
EGP 5.37bn
Highest and lowest close in a year
86.35 – 310.00
Shares traded in the session
22,003
Open the full company record in ESTHMR

A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.

About the company

October Pharma SAE is a Giza-based pharmaceutical company established in April 1987 and listed on the Egyptian Exchange since February 2005. The company operates within the pharmaceuticals, biotechnology, and life sciences sector. Its major shareholders include Arab Company for Drug Industries and Medical Appliances - Egypt (30.835%), Saudi Egyptian for Industrial Investments (28.704%), Joint Arab Investment (15.789%), and Saudi Investment Group and Marketing (13.158%).

Facts from Mubasher

Its record at the exchange

Across 463 filings from 2010 to 2026, the company experienced 24 trading suspensions and 21 resumptions. Its peak filing year was 2017 with 56 disclosures. October Pharma recorded no loss-making periods across 66 reported financial periods from 2012 to 2026. Reported net profit ranged from a low of 2 million EGP in FY 2012 to a peak of 206 million EGP in FY 2025.

Its latest filings at the exchange

  1. Listing committee decisionOctober Pharma (OCPH.CA) - Listing Committee Decision
  2. Shareholders' meetingOctober Pharma (OCPH.CA) - Minutes of the Extraordinary General Assembly Meeting (Notarized)

Insider trades in the exchange’s bulletin

As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.

No insider trades in the company in the exchange bulletins we have read.

Other companies in Health Care & Pharmaceuticals

Page updated with the data of 1 Oct 2026.